All updated as on -
The market for blood and organ banks is anticipated to experience development from 2024 to 2031. From 2024 to 2031, the market is expected to increase at a CAGR of 7.10%. The global population's susceptibility to hemostatic illnesses is driving the demand for blood and organ banks.
An institution that stores blood and its components—including cells, platelets, and plasma—for use in transfusions is called a blood bank. When blood loss occurs due to conditions such as sickle cell anemia, anemia, blood cancer, thalassemia, or an accidental emergency, a blood transfusion may be necessary. In a similar vein, an organ bank is a facility that stores organs for the purpose of transplantation. The term "organ transplantation" describes the surgical procedure of exchanging healthy organs for damaged or dead ones.
The key drivers of the blood and organ bank market include technical advancements and the proliferation of research and development initiatives in the biotechnology sector. Another element pushing things forward is the alarming rise in the prevalence of blood-borne diseases, hematological disorders (such as cancer of the blood, anemia, sickle cell anemia, thalassemia, and others), and infections that can be transmitted through blood transfusions. The market for blood and organ banks is affected by the increase in the number of unintentional instances and the geriatric population. In addition, the growing demand for cell treatment and blood transfusions in developing economies presents lucrative potential for market participants from 2024 to 2031.
Blood and plasma samples are kept in the blood bank for the purpose of transfusions. In situations where blood loss occurs due to an accident or a disorder such thalassemia, sickle cell anemia, blood cancer, or anemia, a blood transfusion may be necessary. Similar to blood banks, organ banks store human organs for the purpose of transplantation. Surgery to replace a damaged or malfunctioning organ with a healthy one is known as an organ transplant.
The aging population, the number of unintentional instances, and the prevalence of hematological illnesses such anemia, sickle cell anemia, and thalassemia are the main factors propelling the industry forward. The market is expanding due to a number of factors, including increased biotechnology research and development studies and heightened public awareness of the issue. Nevertheless, the market is anticipated to be constrained by post-operative consequences including allergic reactions, fever, acute hemolytic reaction, blood-borne infection, and arthritis. There will likely be additional chances in the coming years for blood transfusion and organ transplantation in developing countries.
With a high projected CAGR, the worldwide blood and organ bank market is poised to reach a very sizable valuation in 2027. Blood and organ banks are seeing increased demand from end-users such hospitals and diagnostic centers, according to industry study. This trend is likely to drive industry growth and market expansion throughout the projection period.
The goal of organ transplantation and blood transfusions is to prolong a patient's life and, in some circumstances, to enhance their health. A blood bank is a facility that stores blood and its components, including platelets, plasma, and red blood cells. When people in need have an insufficient amount of blood or blood components, they might receive transfusions from the blood bank. Transplantation relies on organs, tissues, and bones, all of which organ banks handle, recover, store, and distribute. It is estimated that forty to fifty individuals can be saved by a single organ or tissue donation.
The worldwide blood and organ bank market is seeing strong expansion due to the increasing need for transfusion-dependent medical treatments. People in this category mainly consist of those who have kidney problems and need dialysis treatment. Due to excessive blood loss, transfusions of blood are necessary in a number of accident instances. When someone has a severe problem with their organs, transplantation may be an option.
Report Coverage
Global Blood and Organ Bank research report categorizes the market for global based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. Global Blood and Organ Bank report analyses the key growth drivers, opportunities, and challenges influencing the global market. Recent market developments and Blood and Organ Bank competitive strategies such as expansion, product launch and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key Blood and Organ Bank market players and analyses their core competencies in each global market sub-segments.
Key Points Covered in the Report
Competitive Environment:
The research provides an accurate study of the major organisations and companies operating in the global Blood and Organ Bank market, along with a comparative evaluation based on their product portfolios, corporate summaries, geographic reach, business plans, Blood and Organ Bank market shares in specific segments, and SWOT analyses. A detailed analysis of the firms' recent news and developments, such as product development, inventions, joint ventures, partnerships, mergers and acquisitions, strategic alliances, and other activities, is also included in the study. This makes it possible to assess the level of market competition as a whole.
List of Major Market Participants
American National Red Cross, Blood Systems, Inc., MTF Biologics., New York Blood Center, NEW ENGLAND ORGAN BANK, INC., The Living Bank, National Organ & Tissue Transplant Organisation, Global Cord Blood Corporation., CBR Systems, Inc., Vitalant., Terumo Corporation, NHS Blood and Transplant, National Blood Transfusion Council., Sanquin, America’s Blood Centers., Canadian Blood Services., Takeda Pharmaceutical Company Limited., Shanghai RAAS, Macopharma, Haemonetics Corporation, Abbott., Beckman Coulter, Inc. among other
Primary Target Market
Market Segment:
This study forecasts global, regional, and country revenue from 2019 to 2031. INFINITIVE DATA EXPERT has segmented the global Blood and Organ Bank market based on the below-mentioned segments:
Global Blood and Organ Bank Market, By Product
Red Blood Cell Collection, Processing, and Distribution Services
Blood Plasma Collection, Processing, and Distribution Services
Organ Bank Services
Tissue Bank Services
Health Screening Services
All Other Human Blood Services
Reproductive and Stem Cell Bank Services
Global Blood and Organ Bank market, By Activity
Collecting Blood
Storing Blood
Distributing Blood
Storing Organs
Distributing Organs
Researching Storage Technologies
Reproducing Tissues
Global Blood and Organ Bank Market, By End User
Hospitals
Diagnostic Centers
Blood Banks
Others
Global Blood and Organ Bank market, Regional Analysis
An institution that stores blood and its components—including cells, platelets, and plasma—for use in transfusions is called a blood bank. When blood loss occurs due to conditions such as sickle cell anemia, anemia, blood cancer, thalassemia, or an accidental emergency, a blood transfusion may be necessary. In a similar vein, an organ bank is a facility that stores organs for the purpose of transplantation. The term "organ transplantation" describes the surgical procedure of exchanging healthy organs for damaged or dead ones.
The key drivers of the blood and organ bank market include technical advancements and the proliferation of research and development initiatives in the biotechnology sector. Another element pushing things forward is the alarming rise in the prevalence of blood-borne diseases, hematological disorders (such as cancer of the blood, anemia, sickle cell anemia, thalassemia, and others), and infections that can be transmitted through blood transfusions. The market for blood and organ banks is affected by the increase in the number of unintentional instances and the geriatric population. In addition, the growing demand for cell treatment and blood transfusions in developing economies presents lucrative potential for market participants from 2024 to 2031.
Blood and plasma samples are kept in the blood bank for the purpose of transfusions. In situations where blood loss occurs due to an accident or a disorder such thalassemia, sickle cell anemia, blood cancer, or anemia, a blood transfusion may be necessary. Similar to blood banks, organ banks store human organs for the purpose of transplantation. Surgery to replace a damaged or malfunctioning organ with a healthy one is known as an organ transplant.
The aging population, the number of unintentional instances, and the prevalence of hematological illnesses such anemia, sickle cell anemia, and thalassemia are the main factors propelling the industry forward. The market is expanding due to a number of factors, including increased biotechnology research and development studies and heightened public awareness of the issue. Nevertheless, the market is anticipated to be constrained by post-operative consequences including allergic reactions, fever, acute hemolytic reaction, blood-borne infection, and arthritis. There will likely be additional chances in the coming years for blood transfusion and organ transplantation in developing countries.
With a high projected CAGR, the worldwide blood and organ bank market is poised to reach a very sizable valuation in 2027. Blood and organ banks are seeing increased demand from end-users such hospitals and diagnostic centers, according to industry study. This trend is likely to drive industry growth and market expansion throughout the projection period.
The goal of organ transplantation and blood transfusions is to prolong a patient's life and, in some circumstances, to enhance their health. A blood bank is a facility that stores blood and its components, including platelets, plasma, and red blood cells. When people in need have an insufficient amount of blood or blood components, they might receive transfusions from the blood bank. Transplantation relies on organs, tissues, and bones, all of which organ banks handle, recover, store, and distribute. It is estimated that forty to fifty individuals can be saved by a single organ or tissue donation.
The worldwide blood and organ bank market is seeing strong expansion due to the increasing need for transfusion-dependent medical treatments. People in this category mainly consist of those who have kidney problems and need dialysis treatment. Due to excessive blood loss, transfusions of blood are necessary in a number of accident instances. When someone has a severe problem with their organs, transplantation may be an option.
Report Coverage
Global Blood and Organ Bank research report categorizes the market for global based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. Global Blood and Organ Bank report analyses the key growth drivers, opportunities, and challenges influencing the global market. Recent market developments and Blood and Organ Bank competitive strategies such as expansion, product launch and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key Blood and Organ Bank market players and analyses their core competencies in each global market sub-segments.
| REPORT ATTRIBUTES | DETAILS |
|---|---|
| Study Period | 2017-2031 |
| Base Year | 2024 |
| Forecast Period | 2024-2031 |
| Historical Period | 2017-2021 |
| Unit | Value (USD Billion) |
| Key Companies Profiled | American National Red Cross, Blood Systems, Inc., MTF Biologics., New York Blood Center, NEW ENGLAND ORGAN BANK, INC., The Living Bank, National Organ & Tissue Transplant Organisation, Global Cord Blood Corporation., CBR Systems, Inc., Vitalant., Terumo Corporation, NHS Blood and Transplant, National Blood Transfusion Council., Sanquin, America’s Blood Centers., Canadian Blood Services., Takeda Pharmaceutical Company Limited., Shanghai RAAS, Macopharma, Haemonetics Corporation, Abbott., Beckman Coulter, Inc. among other |
| Segments Covered | • By Product |
| Customization Scope | Free report customization (equivalent to up to 3 analyst working days) with purchase. Addition or alteration to country, regional & segment scope |
Key Points Covered in the Report
- Market Revenue of Blood and Organ Bank Market from 2021 to 2031.
- Market Forecast for Blood and Organ Bank Market from 2021 to 2031.
- Regional Market Share and Revenue from 2021 to 2031.
- Country Market share within region from 2021 to 2031.
- Key Type and Application Revenue and forecast.
- Company Market Share Analysis, Blood and Organ Bank competitive scenario, ranking, and detailed company
profiles. - Market driver, restraints, and detailed COVID-19 impact on Blood and Organ Bank
Market
Competitive Environment:
The research provides an accurate study of the major organisations and companies operating in the global Blood and Organ Bank market, along with a comparative evaluation based on their product portfolios, corporate summaries, geographic reach, business plans, Blood and Organ Bank market shares in specific segments, and SWOT analyses. A detailed analysis of the firms' recent news and developments, such as product development, inventions, joint ventures, partnerships, mergers and acquisitions, strategic alliances, and other activities, is also included in the study. This makes it possible to assess the level of market competition as a whole.
List of Major Market Participants
American National Red Cross, Blood Systems, Inc., MTF Biologics., New York Blood Center, NEW ENGLAND ORGAN BANK, INC., The Living Bank, National Organ & Tissue Transplant Organisation, Global Cord Blood Corporation., CBR Systems, Inc., Vitalant., Terumo Corporation, NHS Blood and Transplant, National Blood Transfusion Council., Sanquin, America’s Blood Centers., Canadian Blood Services., Takeda Pharmaceutical Company Limited., Shanghai RAAS, Macopharma, Haemonetics Corporation, Abbott., Beckman Coulter, Inc. among other
Primary Target Market
- Market Players of Blood and Organ Bank
- Investors
- End-users
- Government Authorities
- Consulting And Research Firm
- Venture capitalists
- Third-party knowledge providers
- Value-Added Resellers (VARs)
Market Segment:
This study forecasts global, regional, and country revenue from 2019 to 2031. INFINITIVE DATA EXPERT has segmented the global Blood and Organ Bank market based on the below-mentioned segments:
Global Blood and Organ Bank Market, By Product
Red Blood Cell Collection, Processing, and Distribution Services
Blood Plasma Collection, Processing, and Distribution Services
Organ Bank Services
Tissue Bank Services
Health Screening Services
All Other Human Blood Services
Reproductive and Stem Cell Bank Services
Global Blood and Organ Bank market, By Activity
Collecting Blood
Storing Blood
Distributing Blood
Storing Organs
Distributing Organs
Researching Storage Technologies
Reproducing Tissues
Global Blood and Organ Bank Market, By End User
Hospitals
Diagnostic Centers
Blood Banks
Others
Global Blood and Organ Bank market, Regional Analysis
- Europe: Germany, Uk, France, Italy, Spain, Russia, Rest of Europe
- The Asia Pacific: China,Japan,India,South Korea,Australia,Rest of Asia Pacific
- South America: Brazil, Argentina, Rest of South America
- Middle East & Africa: UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa
About This Research
You will get in-depth and extensive blood and organ bank market market research and competitor analysis for your business to help you develop more profound insights into the blood and organ bank market Market.
Through INFINITIVE Data Expert is a professional Market Research services, I will identify the blood and organ bank market market size, demand & opportunities, growth rate, and target audience with a comprehensive analysis of your competitors.